CD41 Monoclonal Antibody(Q90)

This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia.

The CD41 Monoclonal Antibody (Q90) is a highly specific and reliable tool for the detection and analysis of CD41 antigen expression. This antibody is designed to target the CD41 protein, which is primarily expressed on platelets and megakaryocytes. With its exceptional sensitivity and specificity, the CD41 Monoclonal Antibody (Q90) enables accurate identification and characterization of these cell types in various research and diagnostic applications.

The CD41 Monoclonal Antibody (Q90) is produced using advanced recombinant DNA technology, ensuring a consistent and high-quality product. It has been extensively validated and optimized to provide optimal performance in immunohistochemistry (IHC), immunofluorescence (IF), flow cytometry, and other relevant techniques. This antibody exhibits minimal cross-reactivity with other antigens, ensuring reliable and specific results.

The CD41 Monoclonal Antibody (Q90) offers numerous advantages for researchers and clinicians. Its exceptional sensitivity allows for the detection of low levels of CD41 expression, enabling the identification of rare cell populations. Moreover, its high specificity ensures accurate discrimination between CD41-positive and CD41-negative cells, facilitating precise analysis and interpretation of experimental data.

This antibody is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming and error-prone antibody preparation. It is available in various sizes to accommodate different experimental requirements. Each batch of the CD41 Monoclonal Antibody (Q90) undergoes rigorous quality control procedures to ensure consistent performance and reliability.

In summary, the CD41 Monoclonal Antibody (Q90) is a valuable tool for researchers and clinicians involved in the study of platelets and megakaryocytes. Its exceptional sensitivity, high specificity, and reliable performance make it an indispensable reagent for a wide range of applications, including research, diagnostics, and drug development.